HEATHER RUBINATE: Open Payments
NPI 1891191219 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,415 in 28 payments from 8 companies in 2025. Trend: 2023 $297 · 2024 $524 · 2025 $2,415
Consulting: $1,360Food & beverage: $1,030Travel & lodging: $25
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 10 | $1,697 |
| SANOFI-AVENTIS U.S. LLC | 9 | $389 |
| Legend Biotech USA Inc. | 2 | $137 |
| Amgen Inc. | 1 | $98 |
| GENZYME CORPORATION | 2 | $39 |
| SOBI, INC | 1 | $20 |
| Janssen Scientific Affairs, LLC | 2 | $18 |
| Genentech USA, Inc. | 1 | $15 |
Products named: TALVEY, REZUROCK, CARVYKTI, BLINCYTO, RYBREVANT, SARCLISA, Doptelet, TECVAYLI.
Industry payments across PA — which companies pay providers there.
